Sort by
Refine Your Search
-
Responsibilities: Support the development and continuous improvement of the IMPRS program structures. Coordinate the full recruitment and admission process for PhD candidates. Act as a central communication point
-
The Medical Faculty of Heidelberg and Heidelberg University Hospital are receiving funding from the Federal Ministry for Research, Technology and Space (BMFTR) to establish the program “ACTION
-
Genomics; Epidemiology, Public Health, Prevention and Survivorship; Immunology, Infection & Cancer; and Imaging and Radiology. Participation in cross-cutting programs focused on biomedical engineering and
-
Associate Marga and Walter Boll-Prof. in Cardio-Oncological Epidemiology (W2) with tenure track (W2)
of cardio-oncology research. Other tasks include teaching medical students and participating in the master‘s program in healthcare management. With this professorship, the Faculty of Medicine aims to further
-
position involves teaching pharmaceutical biology in German language as part of our State Examination Programme in Pharmacy. In addition, diploma theses are supervised in the Diploma degree programme in
-
represents the field of Inorganic Chemistry in research and teaching in its entire broadness. We are seeking a candidate who pursues a current, forward-looking, and internationally visible research program in
-
in the degree programs of the Department of Physics. We are searching for an individual who is distinguished by high-ranking scientific publications with international visibility. For a qualitative
-
knowledge within the field of statistics Solid statistical programming skills, preferably with R Very good written and oral communication skills in English Enthusiasm for interdisciplinary collaboration and
-
successfully established “Excellence Professorships” program of the State of Schleswig-Holstein (SH) to support top-level research has been expanded with the funding of another Schleswig-Holstein Excellence
-
and precision prevention in the role of a division head at the DKFZ. The program is expected to build on prostate cancer as a model disease with later expansion to other common tumor entities, e.g